Key Sessions
Mohamed ElSayed
Keynote Presentation: Facilitating APAC Wide and Cross-Broader Collaboration of RNA Medicines - Singapore’s Nucleic Acid Therapeutic Initiative
NATi
Day 1 - UTC+08:00
Day 1
- UTC+08:00
8:00am - 9:00am60 mins
Registration
9:00am - 9:45am45 mins
Keynote
Keynote Panel: Examining Asia-Pacific Government initiatives of RNA Vaccines and Therapeutics
- Mangki Song - Deputy Director General of Science, International Vaccine Institute
- Soon Tuck Sit - Director, BMRC,, A*STAR
- Rosalind Tan - Venture Architect, GRIP
9:45am - 10:15am30 mins
Keynote
Keynote Presentation: RNA Therapeutics: Past, Present and Future
- Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
10:15am - 10:45am30 mins
Keynote
Keynote Presentation: Facilitating APAC Wide and Cross-Broader Collaboration of RNA Medicines - Singapore’s Nucleic Acid Therapeutic Initiative
- Mohamed ElSayed - Executive Director, NATi
10:45am - 11:30am45 mins
Networking Break
11:30am - 12:00pm30 mins
mRNA/mRNA2.0 Clinical Advancements
Presentation: Unlocking Recent Clinical Progress of mRNA-Based Cancer Vaccines & B-Cell Depletion Therapies
- Bo Ying - CEO, Abogen Biosciences
11:30am - 1:00pm90 mins
RNA Leaders Forums
Oligonucleotides: Enabling Biology and Scaling Forum
12:00pm - 12:30pm30 mins
mRNA/mRNA2.0 Clinical Advancements
Presentation: Think Like Resistant Cancer: Turning Tumor RNA Adaptations into Targeted Therapeutics
- Shobha Vasudevan - Senior Group Leader, Principal Investigator, A*STAR
12:30pm - 1:00pm30 mins
mRNA/mRNA2.0 Clinical Advancements
Development of a Decentralized and Accelerated mRNA Vaccine Production System (DeCAFx) to Strengthen Pandemic Preparedness
- Sang Hwan Seo - Director, International Vaccine Institute
1:00pm - 2:00pm60 mins
Lunch
2:00pm - 2:30pm30 mins
Oligonucleotide Innovation
Presentation: Targeting CNS with Oligonucleotide Cargos
- Yacoub Habib - CEO, Ophidion, Inc.
2:00pm - 3:00pm60 mins
RNA Leaders Forums
mRNA Process Development and Manufacturing Forum
2:30pm - 3:00pm30 mins
Oligonucleotide Innovation
Presentation: Advancing Targeted Oligonucleotide Delivery to Muscle and CNS: From Mechanistic Insight to Clinical Translation
- Oxana Beskrovnaya, Ph.D. - Chief Innovation Officer, Dyne Therapeutics
3:00pm - 3:30pm30 mins
Oligonucleotide Innovation
Presentation: Modifying Nucleic Acids for Antisense Applications
- Hideaki Sato - President and CEO, Luxna Biotech
3:30pm - 4:00pm30 mins
Networking Break
4:00pm - 4:30pm30 mins
Translating & Scaling RNA Platforms and Technologies
Presentation: Beyond IVT: Building a Cell-Based Platform for the Next Generation of mRNA Medicines
- Miroslav Gaparek - CEO, Sensible Biotechnologies
4:30pm - 5:00pm30 mins
Translating & Scaling RNA Platforms and Technologies
Presentation: Establishing RNA Technologies in New Zealand
- Rebecca McKenzie - Project Leader RNA Platform, Malaghan Institute
5:00pm - 5:30pm30 mins
Translating & Scaling RNA Platforms and Technologies
Presentation: Improving DNA template generation for high-throughput small-scale RNA production
- Jochem Vink - Development Lead RNA Platform, Ferrier Research Institute
5:30pm - 6:30pm60 mins
Drinks Reception
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。